Meguid El-Nahas

Learn More
We studied here the independent associations of estimated glomerular filtration rate (eGFR) and albuminuria with mortality and end-stage renal disease (ESRD) in individuals with chronic kidney disease (CKD). We performed a collaborative meta-analysis of 13 studies totaling 21,688 patients selected for CKD of diverse etiology. After adjustment for potential(More)
Screening for chronic kidney disease is recommended in people at high risk, but data on the independent and combined associations of estimated glomerular filtration rate (eGFR) and albuminuria with all-cause and cardiovascular mortality are limited. To clarify this, we performed a collaborative meta-analysis of 10 cohorts with 266,975 patients selected(More)
BACKGROUND In recent studies increased amounts of nitric oxide (NO) and apoptosis have been implicated in various pathological conditions in the kidney. We have studied the role of NO and its association with apoptosis in an experimental model of nephrotic syndrome induced by a single injection of adriamycin (ADR). METHODS The alteration in the NO pathway(More)
It is hypothesised that chronic progressive kidney disease may be mediated by abnormalities of lipid metabolism. A series of self-perpetuating secondary events follows an initial glomerular injury. Increased glomerular basement membrane permeability leads to loss of lipoprotein lipase activators, resulting in hyperlipidaemia. Circulating low-density(More)
The prevalence of obesity among patients requiring renal replacement therapy continues to increase inexorably. While observational data have suggested that obesity may be associated with better outcomes among patients on dialysis, many centres have been reluctant to transplant obese patients because of concerns over adverse outcomes in the short and long(More)
A simple, rapid and sensitive method is described for the iodometric determination of microgram amounts of chromium(III), based on the oxidation of chromium(III) with periodate at pH 3.2, removal of the unreacted periodate by masking with molybdate and subsequent iodometric determination of the liberated iodate. Chromium(VI) can be determined by this method(More)
Nephrology, Dialysis and Transplantation Unit, Regina Margherita Hospital, Turin, Italy, Dept of Nephrology, University Medical Center, Leiden, the Netherlands, Nephrology, Fundacion Jimenez Diaz, Madrid, Spain, Sheffield Kidney Institute, Sheffield University, Sheffield, UK, The John Walls Renal Unit, Leicester General Hospital, Leicester, UK, Nephrology(More)
In Reply Because our study was a phase 2B trial with the purpose of finding the optimal dosage with which to conduct a phase 3 outcome trial, strong conclusions should not be drawn from the results. Although Dr Feng and colleagues are correct that change in UACR at day 90 was the primary end point, we understand this is not consistent with any valid renal(More)
  • 1